Results 31 to 40 of about 23,073,058 (182)

PHARMACOECONOMIC BENEFITS OF CYTOMEGALOVIRUS INFECTION PROPHYLACTIC STRATEGY FOR RENAL TRANSPLANT RECIPIENTS [PDF]

, 2011
CMV infection is a major problem in kidney transplantation patients. Valcyte, Cimevene are the first line thera- py of CMV infection. This pharmacoeconomic analysis shown economic benefits of Valcyte prophylaxis tactic compare preemptive ...
V. V. Ryazhenov, S. G. Gorokhova
core   +1 more source

Anesthesia today with the economic and clinical aspects [PDF]

Hospital Pharmacology, 2016
Introduction: The rapid development of knowledge and technology conditions the use of pharmacoeconomic and economic analysis in the system of market economy in health care.
Majstorović Branislava M., Milaković Branko D., Marković Srdjan Z., Kastratović Dragana A.   +3 more
doaj   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings

Фармакоэкономика, 2022
Objective: evaluation of the pharmacoeconomic feasibility of using benralizumab in the form of autoinjector (pen-injector device) in outpatient facilities compared with its use in the form of a syringe in hospital settings for the treatment of severe ...
M. V. Zhuravleva, S. N. Avdeev, Yu. V. Gagarina, T. V. Marin   +3 more
doaj   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Clinical-economic rational of using of prolonged gonadotropin in IVF programs in according to the new opportunities of corifollitropin alfa [PDF]

Гинекология, 2017
Purpose. To define the schemes of induction of superovulation, what are the most pharmacoeconomical founded. Methods. Pharmacoeconomic analysis was performed using the cost minimization analysis on the assumption of equal effectiveness compared schemes ...
T A Nazarenko
doaj  

Pharmacoeconomic analysis of antithrombotic therapy in patients with acute coronary syndrome and patients with atrial fibrillation who underwent percutaneous coronary intervention

Фармакоэкономика, 2023
Objective: to assess the clinical and economic feasibility of ticagrelor in combination with acetylsalicylic acid (ASA) in comparison with clopidogrel in combination with ASA in patients with acute coronary syndrome (ACS), including both those who ...
V. А. Ryagina, К. I. Matrenin, D. G. Shchurov, Т. S. Teptsova   +3 more
doaj   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Pharmacoeconomics of chronic kidney disease

Регуляторные исследования и экспертиза лекарственных средств, 2018
A pharmacoeconomic study is a comprehensive scientific and research activity, which should take into account specific characteristics of a research subject as well as nosology based on common methodological approaches of pharmacoeconomics,.
R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, G. T. Abdrashitova, M. V. Protsenko   +4 more
doaj  

Clinical and economic evaluation of extended-release metformin for the treatment of prediabetes and its impact on the budget and target indicators of federal healthcare projects

Сахарный диабет
BACKGROUND: Patients with prediabetes have an increased risk of developing type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). However, the economic impact of using medications to treat prediabetes has been insufficiently studied.AIM: The ...
N. A. Avxentyev, O. V. Vasyukova, O. M. Drapkina, L. Yu. Drozdova, S. K. Zyryanov, E. R. Kovaleva, A. S. Makarov, Yu. V. Makarova, O. L. Rozenson, V. V. Salukhov, A. V. Sineglazova, O. Y. Sukhareva, M. V. Shestakova   +12 more
doaj   +1 more source